Table 3.
Subjects | Age | Dose and Duration of Supplementation | Form of Vitamin E Used | Infection Organism and Route of Infection | Results: Effects of Vitamin E Supplementation | References |
---|---|---|---|---|---|---|
Mice BALB/c (n = 3–6/group) | 6 months | 100 mg/kg for 8 days before MRSA-challenge | δ-, γ-Tocotrienol | MRSA, inoculated onto superficial surgical wounds | Higher NK cytotoxicity | Pierpaoli et al. 2017 [34] |
Higher IL-24 mRNA expression levels | ||||||
Young and aged male mice C57BL/6 (n = 6/group) | 2, 22–26 months | 500 mg/kg for 4 weeks prior to infection | d-α-tocopheryl acetate | Streptococcus pneumoniae, intra-tracheally injected | 1000-fold fewer bacteria in their lung | Bou Ghanem et al. 2015 [35] |
Age-associated higher production of proinflammatory cytokines (TNF-, IL-6) were reduced | ||||||
3-fold reduction in the number of PMNs | ||||||
Worm-free lambs (n =10/group) | 28–32 weeks | 5.3 IU (3.56 mg)/kg BW for 12 weeks | d-α-tocopherol | H. contortus L3 larvae, route NA | No difference in serum IgG or peripheral mRNA expression of IL-4 or IFN-γ | De Wolf et al. 2014 [36] |
Lower PCV, FEC, and worm burden | ||||||
Male mice BALB/c (n = 6–7/group) | At weaning | Deficient, Adequate (38.4 mg/kg diet), or Supplemented (384 mg/kg diet) for 4 weeks | dl-α-tocopheryl acetate | HSV-1, intranasally | Higher viral titre and ILβ, TNF-α, RANTES in the brain with E deficiency | Sheridan & Beck. 2008 [37] |
No difference in expressions of IL-6, TNFα, IL-1β, and IL-10 between adequate and supplemented | ||||||
Mice C57BL (n = 6–9/group) | 22 months | 500 mg/kg diet for 8 weeks | dl-α-tocopherol acetate | Influenza by nasal inoculation | Lower viral titer | Han et al. 2000 [6] |
Higher IL-2 and IFN-γ production | ||||||
Mice, C57BL/6 (n = 4–9) | 22 months | 500mg/kg diet for 6 weeks | dl-α-tocopherol acetate | Influenza A/PC/1/73 (H3N2) by nasal inoculation | Lower viral titre | Hayek et al. 1997 [7] |
Mice, C57BL/6 (n = 6) | 5 weeks | 160 IU/L liquid diet for 4, 8, 12, 16 weeks | all-rac-α-tocopheryl acetate | Murine LP-BM5 leukaemia retrovirus by IP injection | Restored IL-2 and IFN-γ production by splenocytes following infection | Wang et al. 1994 [38] |
Calves, Holstein (n = 7) | 1d | 1400 or 2800 mg orally once per week, 1400 mg injection once per week for 12 weeks | dl-α-tocopheryl acetate | Bovine rhinotracheitis virus, in vitro | Serum from vitamin E-supplemented calves inhibited the replication of bovine rhinotracheitis virus in vitro | Reddy et al. 1986 [39] |
Mice, Swiss Webster (n = 10) | 4 weeks | 180 mg/kg diet for 4 weeks | dl-α-tocopheryl acetate | Diplococcus pneumoniae type I by IP injection | Higher survival | Heinzerling et al. 1974a [5] |
Mice, BALB/C (n = 25) | NA | 25 or 250 mg/kg bw orally for 4 days, starting 2 days before burn injury | dl-α-tocopheryl acetate | Pseudomonas aeruginosa, subeschar injection to burned mice | Lower mortality rate | Fang et al. 1990 [40] |
Mice, BALB/C (NA) | 3 weeks | 4000mg/kg diet for 2, 4, or 14 weeks | Vitamin E injectable (aqueous) | Listeria monocytogenes by IP injection | No difference in resistance | Watson & Petro 1982 [41] |
Rats, Sprague-Dawley (n = 6) | 3 weeks | 180 mg/kg diet + 6000 IU vitamin A/kg diet for 6 weeks | dl-α-tocopheryl acetate | Mycoplasma pulmonis by aerosol | Higher resistance to infection | Tvedten et al. 1973 [42] |
Lambs (n = 10) | NA | 1000 IU orally, 300 mg/kg diet for 23 days | dl-α-tocopheryl acetate | Chlamydia by intratracheal inoculation | Faster recovery (higher food intake and weight gains) | Stephens et al. 1979 [43] |
Turkey, broadbreasted white poults (n = 6) | 1 day | 500 mg/kg diet for 14 days before infection and 18–21 days after infection | dl-α-tocopheryl acetate | Histomonas meleagridis, oral | No effect on mortality by vitamin E supplementation alone | Schildknecht & Squibb 1979 [44] |
Lower mortality and lesion score in combination with ipronidazole | ||||||
Pigs (n = 6) | NA | 200 mg/pig per day for 59 days before infection and 22 days after infection | dl-α-tocopheryl acetate | Treponema hyodysenteriae, oral | Improved weight gain and recovery rate | Teige et al. 1982 [45] |
No beneficial effect on appetite and diarrhoea | ||||||
Sheep (n = 12) | 3–6 months | 300 mg/kg diet starting 2 weeks before first vaccination | dl-α-tocopheryl acetate | Clostridium perfringens type D by IV injection after two IM vaccinations | Higher Ab titre | Tengerdy et al. 1983 [46] |
Fail to prove beneficial effect of vitamin E on protection (none of the vaccinated lambs died) | ||||||
Cows (n = 20) | NA | 740 mg/cow per day, duration NA | dl-α-tocopheryl acetate | Natural occurrence of clinical mastitis due to Streptococci, Coliform, Staphylococci, Clostridium bovis | Lower clinical cases of mastitis | Smith et al. 1984 [47] |
Chicks, broiler (n = 12–14) | 1day | 150 mg or 300mg/kg diet for 2 weeks before infection | dl-α-tocopheryl acetate | Escherichia coli, orally and post-thoracic air sac | Lower mortality | Heinzerling et al. 1974b [48] |
Higher Ab titre | ||||||
Chicks, broiler (n = 10) | 1 day | 300 mg/kg diet for 6 weeks, starting 3 weeks before first infection | dl-α-tocopheryl acetate | E. coli, post-thoracic air sac | Lower mortality | Tengerdy & Nockels 1975 [49] |
Chicks, Leghorn (n = 22) | 1 day | 300 mg/kg diet for 4 weeks before infection | dl-α-tocopheryl acetate | E. coli by IV injection | Lower mortality | Likoff et al. 1981 [50] |
Pigs (n = 10) | 6–8 weeks | 100, 000 mg/t diet for 10 weeks, starting 2 weeks before infection | Vitamin E; Tompson-Hayward, Minneapolis, MN, USA | E. coli by IM injection | Higher serum Ab titre | Ellis & Vorhies 1976 [51] |
Ab, antibody; FEC, fecal egg count; HSV, Herpes simplex virus; MRSA, IFN-γ, interferon-γ; IM, intramuscular; IV, intravenous; Methicillin-resistant Staphylococcus aureus; NK, natural killer; PCV, packed cell volume; PMN, polymorphonuclear leukocyte, RANTES, regulated on activation, normal T cell expressed and secreted; TNF-α, tumor necrosis factor-α.